◆ 会议时间：2023年7月24日至27日
◆ 会议地点：美国 芝加哥
◆ 会议简介：
2023年STI&HIV世界大会将于2023年7月24日至27日在美国芝加哥举行，第25届国际性传播疾病研究学会(ISSTDR)会议/第24届国际性病控制联盟(IUSTI)世界大会作为联席会议举行。
STI&HIV世界大会是国际性传播疾病研究学会(ISSTDR)和国际抗性传播疾病联盟(IUSTI)的联席会议，每两年举行一次。STI/HIV世界大会是性传播感染领域规模最大的国际性会议之一，吸引了来自世界各地的代表参加。会议将为世界上最杰出的研究人员和相关专业人士提供一个极好的机会，共同致力于改善包括艾滋病毒在内的性传播感染领域的全球公共卫生。会议将为与会者提供与专家进行交流的机会，并向国际听众介绍他们的研究成果，听取世界各国领导人在性病/艾滋病领域的最新科学研究进展，为影响世界各地未来的卫生政策和患者护理的讨论作出贡献。
国际性病控制联盟 (IUSTI)成立于1923年，是历史最悠久的致力于性传播感染（包括HIV/AIDS）预防与控制的非营利性国际组织，同时也是在世界卫生组织具有咨商地位的官方非政府组织宣。IUSTI关注性传播感染及其控制医学、科学和流行病学等方面。国际性病控制联盟(IUSTI)每年举办一次世界大会，每两年同ISSTDR联合举办一次STI & HIV世界大会；IUSTI世界大会旨在增强世界各地区在性传播感染（包括HIV/AIDS）预防和控制方面的学术交流与合作，内容涉及基础和实验室科学、诊断学、流行病学和监测、临床管理和治疗、公共卫生计划和预防等方面。未经许可禁止复制转载镜像本站任何内容—领域国际医学会议网(lingyuint.com)。
国际性传播疾病研究协会（ISSTDR）成立于1977年，其宗旨是促进性传播疾病的研究，并促进研究人员之间及时地进行信息交流。ISSTDR每两年同IUSTI联合举办一次STI & HIV世界大会。ISSTDR的会议是行业内首屈一指的科学会议，涉及包括艾滋病毒感染和获得性免疫缺陷综合征在内的整个STD研究领域，包括微生物学、病毒学、免疫生物学、发病机制和其他基础科学；临床科学、社会和行为科学、流行病学和预防；以及在卫生服务、公共卫生和预防政策方面的研究等等。
STI & HIV 2021 World Congress
Date: July 24-27, 2023
Location：
Sheraton Grand Chicago Riverwalk, Chicago, USA
The 25th ISSTDR meeting will be held as a joint meeting with the 24nd IUSTI World meeting.
Chair: Barbara J. Van der Pol.
摘要征文投稿：
Abstracts are due on January 13,2023.
The descriptions and topic examples are provided as guides and are not meant to represent an exhaustive list of topics. CLICK HERE to download the category descriptions.
All abstracts should be submitted in the Scientific Data Abstract Format unless involving programmatic or descriptive (not data-driven) studies, which may be submitted in the Experiential/Observational Summary Format.
Scientific data abstracts should not exceed 350 words and can include one table and one figure separate from the abstract. The abstract should contain these four sections with bolded section headings within the text of the abstract submission.
- Background: State the study aim/objectives, hypothesis tested, or description of the problem. Should explain why the abstract is important or novel or provide context/explanation for the doing study.
- Methods: Methods for testing and data analysis (specific statistical analyses conducted, specific population studied, selection and origin of specimens evaluated, and standard used for comparison).
- Results: Specific results with appropriate statistical analysis. Describe your main findings with data. Statements such as “to be completed” or “to be presented” are not acceptable.
- Conclusion: Explain your main findings and why they are important. Conclusions should be supported by the findings. Concluding statements such as “the results will be discussed” are not acceptable
Experiential/Observational summary abstracts should not exceed 350 words and can include one table and one figure separate from the abstract. The abstract should contain these four sections with bolded section headings within the text of the abstract submission. Section headings do not count toward the word count.
- Project: Description of the project
- Issue: Specific project problems or needs addressed by the abstract
- Results: Qualitative or quantitative summary of implementation facilitators and barriers
- Lessons Learned: Summary of lessons learned and implications
Please do not include grant acknowledgements, literature references, or copyright or trademark symbols.
Scholarship Assistance: If you need assistance to attend the meeting, you may apply for a scholarship. Priority will be given to students and young investigators with a focus on those attending from lower and middle income countries. Resources are limited so scholarships will be determined based on quality of you submission and description of need as well as the factors above. In order to apply, you will need to upload either proof of student status OR your certificate/diploma from your last training program and you will need to write a short statement explaining why you need support from the Congress. If you do not have these documents at the time of your abstract submission, you can SAVE your work and return to upload documents at a later time (prior to the abstract deadline).
注册费：
Early Bird Registration (January 23, 2023 – March 31, 2023)
| Full Rate |
$900 (ASTDA or IUSTI discounts may apply) |
| US Public Health Agency employees |
$800 (***.gov email, no additional discounts) |
| Full-time students |
$600 (no additional discounts) |
| Lower/Middle Income Country participants |
$500 (IUSTI discount may apply) |
Regular Registration (April 1, 2023 – May 31, 2023)
| Full Rate |
$1,100 (ASTDA or IUSTI discounts may apply) |
| US Public Health Agency employees |
$1,000 (***.gov email, no additional discounts) |
| Full-time students |
$700 (no additional discounts) |
| Lower/Middle Income Country participants |
$550 (IUSTI discount may apply) |
Late Registration (June 1, 2023 – Onwards)
| Full Rate |
$1,200 (ASTDA or IUSTI discounts may apply) |
| US Public Health Agency employees |
$1,100 (***.gov email, no additional discounts) |
| Full-time students |
$800 (no additional discounts) |
| Lower/Middle Income Country participants |
$600 (IUSTI discount may apply) |
Your Join us on Wednesday evening of the conference for the Chicago Odyssey Fireworks Dinner Cruise! Enjoy dining and dancing with fellow conference attendees as we sail the scenic Chicago River onto Lake Michigan on a private charter. Limited seating is available so reserve your place now.
$95 for Conference Attendees and $155 for Non-registered Guests
◆ 参会对象：免疫学家，生物学家，医生、医院科室主任/副主任、住院医师、医院管理者、医护人员以及从事该领域研究的科学家、研究人员、医药企业代表等等。
|
